Turnover—
EBIT margin—
Net result€-189k
Working capital€482k
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of OLFADOG BIOTECH is 1.0% (low). The 2024 annual accounts show equity of €1.44M and a net result of €-189k. Its solvency ranks better than 78% of 52 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 1 annual account.
Financials
FY 2024
€1.44M
equity
Turnover—
Net result€-189kHealth55/100 · Fair
See full annual accounts
People & board
No director data processed yet.
To directors Publicationslatest 06-01-2025
2
publications in the State GazetteCapital increase of €786,417 to €2,035,417All publications & acts Network & structure
No network or structure data processed.
To structure
Trust signals
3 signalsMore than 3 years active
Founded in 2022 — past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone1.0%
Low
0%0,5%1,5%4%10%≥25%
Young company
+Lower-failure-rate sector
−Lower-risk legal form
−
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Company registry (CBE)
Crossroads BankActivities
Speur- en ontwikkelingswerk op biotechnologisch gebied72101Speur- en ontwikkelingswerk op biotechnologisch gebied72110
Primary activity highlighted.
Names & trade names
| Legal nameFR | OLFADOG BIOTECH |
| AbbreviationFR | OLFADOG |
Registered office
Drève Richelle 161P bus 4
1410 Waterloo, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.